中国医疗集团截至二零二四年十二月三十一日止之年度报告

2024 CHINA HEALTH GROUP INC.中國醫療集團有限公司 (Carrying on business in Hong Kong as“萬全醫療集團”)(以「萬全醫療集團」名稱在香港經營業務)(Incorporated in the Cayman Islands with limited liability)(於 開 曼 群 島 註 冊 成 立 之 有 限 公 司)(Stock Code: 08225)(股份代號: 08225) 截至二零二四年十二月三十一日止之年度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED(THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higherinvestment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be awareof the potential risks of investing in such companies and should make the decision to invest only after due and carefulconsideration. Given that the companies listed on GEM are generally small and mid-sized companies, there is a risk that securities tradedon GEM may be more susceptible to high market volatility than securities traded on the Main Board and no assurance isgiven that there will be a liquid market in the securities traded on GEM. Hong Kong Exchanges and Clearing Limited and the Stock Exchange take no responsibility for the contents of this report, make norepresentation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arisingfrom or in reliance upon the whole or any part of the contents of this report. This report for which the directors (the “Directors”) of China Health Group Inc. (the “Company” and together with its subsidiaries,the “Group”) collectively and individually accept full responsibility, includes particulars given in compliance with the RulesGoverning the Listing of Securities on the GEM of the Stock Exchange (the “GEM Listing Rules”) for the purpose of givinginformation with regard to China Health Group Inc. The Directors, having made all reasonable enquires, confirm that, to the bestof their knowledge in for mufion and belief: (1) the information contained in this report is accurate and complete in all materialrespects and not misleading or deceptive; (2) there are no other matters the omission of which would make any statement in thisreport herein or this report misleading; and (3) all opinions expressed in this report have been arrived at after due and carefulconsideration and are found on bases and assumptions that are fair and reasonable. 目錄C O N T E N T S .............................................................................................................1Corporate InformationChairman’s StatementFinancial HighlightsManagement Discussion and AnalysisProfile of Directors and Senior ManagementDirectors’ ReportCorporate Governance ReportIndependent Auditor’s ReportConsolidated Statement of Profit or Loss and Other Comprehensive IncomeConsolidated Statement of Financial PositionConsolidated Statement of Changes in EquityConsolidated Statement of Cash FlowsNotes to the Consolidated Financial StatementsFive Years Financial Summary..............................................................................................................3..............................................................................................................6...............................................................................................7......................................................................................13..........................................................................................................16......................................................................................................30.................................................................................................48..................................................................................................55..............................................................................54..................................................................................................56..................................................................................................58..............................................................................................59....................................................................................................106 ̃ٽᭅ̃
"//6"-
3&1035 公司资料CORPORATE INFORMATION BOARD OF DIRECTORS EXECUTIVE DIRECTORS:Mr. GUO Xia (Chairman)Mr. Raymond GUO (appointed on 11 September 2024)Dr. SONG Xuemei (resigned on 11 September 2024) NON-EXECUTIVE DIRECTORS:Dr. ZHANG LiDr. WANG Dajun Denis (appointed on 5 February 2024 andresigned on 17 January 2025) INDEPENDENT NON-EXECUTIVE DIRECTORS: Dr. NI BinhuiDr. GUO TongMr. WU Shuangsi (appointed on 5 February 2024)Ms. LIU Na (appointed on 12 March 2024)Mr. QIU Rui (resigned on 5 February 2024) AUDIT COMMITTEE Ms. LIU Na (Chairman) (appointed on 12 March 2024)Dr. NI BinhuiDr. GUO TongMr. WU Shuangsi (appointed on 5 February 2024)Mr. QIU Rui (resigned on 5 February 2024) NOMINATION COMMITTEE Dr. NI Binhui (Chairman)Mr. GUO XiaMr.